Unconjugated bilirubin alleviates experimental ulcerative colitis by regulating intestinal barrier function and immune inflammation

Figure 1 UCB significantly relieved severity of dextran sulfate sodium induced colitis. A: Body weight changes, data plotted as percentage of basal body weight; B: Disease activity index; C: Changes in colon length; D: Relative spleen weight. Data are expressed as means ± SEM (n = 5). ^aP < 0.05, ^bP < 0.01, and ^cP < 0.001 vs control group, ^dP < 0.05, ^eP < 0.01, and ^fP < 0.001 vs dextran sodium sulfate group. UCB: Unconjugated bilirubin; DSS: Dextran sodium sulfate; SEM: Standard error of the mean.